This week PharmaShots’ news was all about the updates on Regulatory, Clinical Trials,Pharma, Animal Health & MedTech. Check out our full report below:

The US FDA Approves Merck’s Keytruda + Chemoradiotherapy for Treating FIGO 2014 Stage III-IVA Cervical Cancer

Read More: Merck                                                                    

MHRA Grants Approval to Santhera’s Agamree (Vamorolone) for Treating Duchenne Muscular Dystrophy

Read More: Santhera                                                                     

The EC Grants Marketing Authorization to the Subcutaneous Formulation of Tecentriq for Multiple Cancers

Read More: Roche                                                                   

The US FDA has Cleared the IND Application of InnoCare Pharma’s for ICP-248 to Treat Hematological Malignancies

Read More: InnoCare Pharma                                                                 

The US FDA Updates Sanofi’s Dupixent Label for its Use in Atopic Dermatitis

Read More: Sanofi                                                               

The US FDA Clears Aruna Bio’s IND Application of AB126 for Neurological Indications

Read More: Aruna Bio                                                             

The EC Grants ODD to Precigen’s PRGN-2012 for Recurrent Respiratory Papillomatosis (RRP)

Read More: Precigen                                                             

The US FDA Approves Takeda’s Hyqvia as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Read More: Takeda                                                         

The Injection Formulation of Eisai’s Fycompa (perampanel) Receives MHLW’s Marketing Authorization for Epilepsy

Read More: Eisai                                                                

MHLW Grants Approval to argenx’s Vyvdura Injection for Generalized Myasthenia Gravis

Read More: argenx                                                               

Sensorion Obtains Approval to Conduct P-I/II Study of SENS-501 (OTOF-GT) for Hearing Impairment Across European Countries

Read More: Sensorion                                                             

The EPO Grants Patent to GH Research’s Mebufotenin (5-MeO-DMT) and its Salt Products for Major Depressive Disorder and Treatment-Resistant Depression

Read More:  GH Research                                                           

Arcutis Biotherapeutics Highlights the P-III Resutls for Zoryve Cream for the Treatment of Atopic Dermatitis

Read More: Arcutis Biotherapeutics                                                        Date: Jan 15, 2023

Arcutis Biotherapeutics Reports Data from the STRATUM Study of Zoryve (Roflumilast) Topical Foam, 0.3% for Seborrheic Dermatitis

Read More: Arcutis Biotherapeutics                                                        Date: Jan 15, 2023

AM-Pharma Reports Initiation of P-II Study Investigating Ilofotase Alfa for Cardiac Surgery-Associated Renal Damage 

Read More: AM-Pharma                                                        Date: Jan 16, 2023

Galderma to Highlight Results from the P-III (READY-3) Study of RelabotulinumtoxinA for Treating Frown Lines and Crow’s Feet at TOXINS 2024

Read More: Galderma                                                               Date: Jan 17, 2023

PeproMene Bio Reveals Results from the P-I Study of PMB-CT01 for Treating R/R B-Cell Acute Lymphoblastic Leukemia

Read More: PeproMene Bio                                                                

Coherus Presents Data from the P-II Study of Casdozokitug for Advanced or Metastatic Hepatocellular Carcinoma (uHCC)

Read More: Coherus                                                                          

Andelyn Biosciences and Armatus Bio Collaborate to Manufacture Gene Therapy for Charcot-Marie-Tooth Type 1A (CMT1A)

Read More: Andelyn Biosciences & Armatus Bio                                                       

Xenetic Biosciences and University of Virginia Collaborate to Advance DNase-Based Oncology Platform

Read More: Xenetic Biosciences & University of Virginia                               

AbbVie and Enigma Biomedical Group (EBG-USA) Collaborate to Develop and Commercialize 4R Tau PET Imaging Biomarkers

Read More: AbbVie & Enigma Biomedical Group                               

Boan Biotech Reports Clinical Updates for BA6101 (biosimilar, Prolia) and BA1102 (biosimilar, Xgeva) to Treat Various Indications

Read More: Boan Biotech                                                      

For an Aggregate of $2.34M, Basilea Pharmaceutica Acquires Spexis’ Preclinical Antibiotics Program

Read More: Basilea Pharmaceutica                                                       

Vision Sensing Acquisition and Mediforum Sign a Definitive Merger Agreement

Read More: Vision Sensing Acquisition & Mediforum                           

Sun Pharma and Taro Pharmaceutical Sign a Definitive Merger Agreement

Read More: Sun Pharma & Taro Pharmaceutical                             

Delcath Systems Lanches Hepzato Kit in the US for Treating Metastatic Uveal Melanoma (mUM)

Read More: Delcath Systems                                                               

Abbott Conducts First Global Procedure in the Study of Volt PFA System for Abnormal Heart Rhythms

Read More: Abbott                                                                             

Merck Animal Health Highlights the Updates from the Study Assessing the Mental Health and Well-Being of US Veterinarians

Read More: Merck Animal Health                                                    

ELIAS Animal Health Highlights Data from the (ECI-OSA-04) Study of ELIAS Cancer Immunotherapy (ECI) for Treating Dogs with Bone Cancer

Read More: ELIAS                                                              

The US FDA Approves Darmiyan’s BrainSee to Detect Alzheimer’s Dementia 

Read More: Darmiyan                     

Related Post:-  PharmaShots Weekly Snapshots (January 08 – January 12, 2024)